Akèy › Karsinòm Nèwo-endokrin › New York › New York City
Etid klinik pou Karsinòm Nèwo-endokrin nan New York City, NY
6 etid pou Karsinòm Nèwo-endokrin ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Ap rekriteFaz 1
- Icahn School of Medicine at Mount Sinai, New York
A Study of Armored CAR T Cells in People With Cancer
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
Ap rekriteFaz 1
- NYU Langone Health, New York
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Ap rekriteFaz 1/2
- NYU Langone Health, New York
- Icahn School of Medicine At Mount Sinai Prime, New York
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Ap rekriteFaz 1/2
- Crinetics Study Site, New York
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Ap rekriteFaz 1/2
- Columbia University Medical Center - Herbert Irving Pavilion, New York
Etid Karsinòm Nèwo-endokrin nan lòt vil
- Houston, TX6 etid
- Arlington, VA5 etid
- Dallas, TX4 etid
- Los Angeles, CA4 etid
- Washington, DC4 etid
- Columbus, OH3 etid
- St. Louis, MO3 etid
- Grand Rapids, MI3 etid
- Atlanta, GA3 etid
- Denver, CO3 etid
- New Haven, CT3 etid
- Nashville, TN3 etid
Lòt etid nan New York City
- Kansè nan tete136 etid
- Kansè Poumon ki pa ti selil121 etid
- Kansè (tout kalite)109 etid
- Kansè pwostat103 etid
- Kansè Metastatik93 etid
- Kansè kolorektal78 etid
- Kansè ovè69 etid
- Kansè poumon60 etid
- Myelom Miltip60 etid
- Kansè pankreyas60 etid
- Kansè Endomèt52 etid
- Leksemi mieloïd egi51 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.